Lazard Capital Markets

Lazard Capital Markets has upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Hold to Buy and has established a $33 price target following the settlement of patent litigation with Teva Pharmaceuticals (NASDAQ: TEVA).

Lazard Capital Markets has upgraded XenoPort (NASDAQ: XNPT) from Sell to Hold.

Lazard Capital has downgraded GSI Commerce (NASDAQ: GSIC) from Buy to Hold following eBay's (NASDAQ: EBAY) acquisition offer.

Lazard Capital Markets has downgraded Amworth Mortgage (NYSE: ANH) from Buy to Hold.

Lazard Capital Markets has downgraded Annaly Capital Management (NYSE: NLY) from Buy to Hold.

Lazard Capital has upgraded Kenexa Corporation (NASDAQ: KNXA) from Hold to Buy with a $30 price target.

Lazard Capital has downgraded CDC Software (NASDAQ: CDCS) from Buy to Hold.

Lazard Capital Markets has issued a report giving Micron Technology (NASDAQ: MU) a Buy Rating. According to the report, "MU posted $2.257B in rev and EPS of $0.07, better than LCMe of $2.01B/$0.04 and the Street's $2.065B/$0.04. GM came in at 19% vs. our estimate of 22%, but the company benefited...

In a report published by Lazard Capital Markets, it is lowering estimates on Cree (NASDAQ: CREE). Lazard said that it is lowering our F3Q estimates to $216.5M/$0.31 from $252M/$0.40 following Cree's preannouncement. “The Street expects $254M/$0.42. For F4Q, we now see $240.3M/$0.37 vs. $260M/$0.41...

Lazard Capital Markets provided color on Broadcom (NASDAQ: BCOM) on day two of their Tech and Media Conference in a report published today. In the report, Lazard states, "In the networking area the company is working to integrate 1) EPONs and switch processors; 2) Processing cores with switches;...

According to Barron’s, shares of Forest Laboratories, Inc. (NYSE: FRX), which dropped by 13.77% in trading on Thursday, look cheap. The company’s shares fell after an advisory panel of the FDA voted by 10-to-5, rejecting Daxas, a drug used for treating chronic obstructive pulmonary disease (COPD),...

Analyst Urs Dur at Lazard Capital Markets has released an update on Westway Group, Inc. (NASDAQ: WWAY). Lazard Capital Markets has lowered its estimates for the company after analyzing its fourth-quarter results. It has lowered first-quarter EPS from $0.06 to $0.05. FY 2010 EPS has been lowered...

Analysts Graham Mattison, Sanjay Shrestha and Sarah Martin at Lazard Capital Markets have released an update on ADA-ES, Inc. (NASDAQ: ADES). The company has reported its fourth-quarter results. ADA-ES reported fourth-quarter loss of $0.18 per share, which was lower than the consensus estimate of a...

Analysts David W. Parker and Jennifer Dugan at Lazard Capital Markets have released an update on Paychex, Inc. (NASDAQ: PAYX). Analysts believe that the company is starting to see a slight improvement in key metrics and appears well positioned to benefit from any type of rebound. However, analysts...